Skip to main content

Table 3 Oxidative status in the study groups

From: Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study

 

CRF

HD

PD

TBARS (μmol.L-1)

0.12 ± 0.01

0.23 ± 0.02*

0.18 ± 0.01*

TBARS-VLDL (μmol.L-1)

0.55 ± 0.02

0.10 ± 0.05**

0.026 ± 0.014**

TBARS-LDL (μmol.mL1)

0.038 ± 0.002

0.055 ± 0.023*

0.052 ± 0.014*

TBARS-HDL2 (μmol.mL1)

0.09 ± 0.01

0.047 ± 0.008*

0.023 ± 0.01*#

TBARS-HDL3 (μmol.mL1)

0.196 ± 0.05

0.105 ± 0.070

0.231 ± 0.049

Carbonyls (μmol.mL1)

0.3 ± 0.16

0.92 ± 0.15*

1.90 ± 0.10**##

  1. CRF: End stage chronic renal failure patients. HD: patients on hemodialysis. PD: Patients on peritoneal dialysis. Data are presented as the mean ± SD. * HD group and PD group vs CRF group # HD group vs PD group. *#(P < 0.05); **##(P < 0.01)